| Literature DB >> 23483621 |
Elisabeth T Korthof1, Johanna Svahn, Regis Peffault de Latour, Paola Terranova, Helene Moins-Teisserenc, Gérard Socié, Jean Soulier, Marleen Kok, Robbert G M Bredius, Maarten van Tol, Els C M Jol-van der Zijde, Angela Pistorio, Fabio Corsolini, Alessia Parodi, Florinda Battaglia, Vito Pistoia, Carlo Dufour, Enrico Cappelli.
Abstract
In this study, the immunological status of 61 patients with Fanconi anemia (FA) with advanced marrow failure before hematopoietic stem cell transplantation was analyzed by assessing the phenotype of peripheral blood lymphocytes, serum immunoglobulin (Ig) levels, and inflammatory cytokines. In patients with FA, total absolute lymphocytes (P < 0.0001), B cells (P < 0.0001), and NK cells (P = 0.003) were reduced when compared with normal controls. T cells (CD3), that is, cytotoxic T cells, naïve T cells, and regulatory T cells, showed a relative increase when compared with controls. Serum levels of IgG (P < 0.0001) and IgM (P = 0.004) were significantly lower, whereas IgA level was higher (P < 0.0001) than in normal controls. TGF-β (P = 0.007) and interleukin (IL)-6 (P = 0.0007) levels were increased in the serum of patients when compared with controls, whereas sCD40L level decreases (P < 0.0001). No differences were noted in the serum levels of IL-1β, IL-2, IL-4, IL-10, IL-13, IL-17, and IL-23 between FA subjects and controls. This comprehensive immunological study shows that patients with FA with advanced marrow failure have an altered immune status. This is in accordance with some characteristics of FA such as the proinflammatory and proapoptotic status. In addition, B lymphocyte failure may make tight and early immunological monitoring advisable.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23483621 DOI: 10.1002/ajh.23435
Source DB: PubMed Journal: Am J Hematol ISSN: 0361-8609 Impact factor: 10.047